Answers are grounded in this paper and cite their sources.
One-fifth of people with drug-resistance tuberculosis (DR-TB) who were initiated on newer shorter treatment regimen (with injection) had unfavourable treatment outcomes in India as on 2020. Evidence on self-driven solutions and resilience adapted by people with DR-TB (PwDR-TB) towards their multi-dimensional disease and treatment challenges are scarce globally, which we aimed to understand.
No takes yet. Share an insight, caveat, or question.
Nagarajan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: